Severe SARS-CoV-2 Infection With Multiorgan Involvement Followed by MIS-C in an Adolescent
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Children and adolescents with coronavirus disease 2019 (COVID-19) generally have mild symptoms. Severe infection due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) involving multiorgan dysfunction is rare in this population. Herein, we present an unusual case of severe SARS-CoV-2 infection with multiorgan involvement followed by multisystem inflammatory syndrome in children (MIS-C) in a vaccinated 16-year-old boy. The patient was unconscious on initial presentation, and had severe paralytic ileus. On laboratory examination, there was severe metabolic acidosis, lymphocytopenia, thrombocytopenia, elevated inflammatory markers, elevated liver enzymes, and evidence of acute kidney injury with proteinuria and hematuria. His symptoms improved with the administration of remdesivir and dexamethasone. The patient briefly experienced MIS-C 2 weeks after the diagnosis of COVID-19, but the patient was discharged without any complications.
Abstract
Children and adolescents with coronavirus disease 2019 (COVID-19) generally have mild symptoms. Severe infection due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) involving multiorgan dysfunction is rare in this population. Herein, we present an unusual case of severe SARS-CoV-2 infection with multiorgan involvement followed by multisystem inflammatory syndrome in children (MIS-C) in a vaccinated 16-year-old boy. The patient was unconscious on initial presentation, and had severe paralytic ileus. On laboratory examination, there was severe metabolic acidosis, lymphocytopenia, thrombocytopenia, elevated inflammatory markers, elevated liver enzymes, and evidence of acute kidney injury with proteinuria and hematuria. His symptoms improved with the administration of remdesivir and dexamethasone. The patient briefly experienced MIS-C 2 weeks after the diagnosis of COVID-19, but the patient was discharged without any complications.
참고문헌 (20)
- Cui X, "A systematic review and meta-analysis of children with coronavirus disease 2019(COVID-19)", J Med Virol, 93, pp.1057~1069 (2021)
- Irfan O, "Clinical characteristics, treatment and outcomes of paediatric COVID-19 : a systematic review and meta-analysis", Arch Dis Child, 106, pp.440~448 (2021)
- Kompaniyets L, "Underlying medical conditions associated with severe COVID-19 illness among children", JAMA Netw Open, 4, pp.e2111182~ (2021)
- Fernandes DM, "Severe acute respiratory syndrome coronavirus 2 clinical syndromes and predictors of disease severity in hospitalized children and youth", J Pediatr, 230, pp.23~31 (2021)[DOI]
- Shekerdemian LS, "Characteristics and outcomes of children with coronavirus disease 2019(COVID-19)infection admitted to US and Canadian pediatric intensive care units", JAMA Pediatr, 174, pp.868~873 (2020)
- "CDCHAN-00432, May 14, 2020. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19)" (2020)[URL]
- Lindan CE, "Neuroimaging manifestations in children with SARS-CoV-2 infection : a multinational, multicentre collaborative study", Lancet Child Adolesc Health, 5, pp.167~177 (2021)
- Beaudry JT, "Fatal SARS-CoV-2inflammatory syndrome and myocarditis in an adolescent : a case report", Pediatr Infect Dis J, 40, pp.e72~6 (2021)
- Bjornstad EC, "Kidney implications of SARS-CoV2 infection in children", Pediatr Nephrol, 37, pp.1453~1467 (2022)
- Dallan C, "Septic shock presentation in adolescents with COVID-19", Lancet Child Adolesc Health, 4, pp.e21~3 (2020)
- Joshi K, "Cardiac dysfunction and shock in pediatric patients with COVID-19", JACC Case Rep, 2, pp.1267~1270 (2020)
- Gupta A, "Extrapulmonary manifestations of COVID-19", Nat Med, 26, pp.1017~1032 (2020)
- Hoffmann M, "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", Cell, 181, pp.271~280.e8 (2020)
- Chou J, "Immunology of SARS-CoV-2 infection in children", Nat Immunol, 23, pp.177~185 (2022)
- Nemani K, "Association of psychiatric disorders with mortality among patients with COVID-19", JAMA Psychiatry, 78, pp.380~386 (2021)
- Mokhtari R, "The major histocompatibility complex(MHC)in schizophrenia : a review", J Clin Cell Immunol, 7, pp.479~ (2016)
- Steiner J, "Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity", Eur Arch Psychiatry Clin Neurosci, 260, pp.509~518 (2010)
- De Leon J, "Data from the World Health Organization’s pharmacovigilance database supports the prominent role of pneumonia in mortality associated with clozapine adverse drug reactions", Schizophr Bull, 46, pp.1~3 (2020)
- "Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C)" (2021)[URL]
- Kaushik A, "A systematic review of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection", Pediatr Infect Dis J, 39, pp.e340~6 (2020)